MedPath

Evaluation of the effect of intraperitoneal injection of Bupivacain 0.5% in post operation nausea and vomiting in laparascopic cholecystectomy

Phase 2
Conditions
nausea and vomiting resolve after laparscopic cholecystectomy.
Postcholecystectomy syndrome
Registration Number
IRCT201110287928N1
Lead Sponsor
Ahvaz Jundishapur University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

inclusion criteria: 20-60 years old without diabetes mellitus, hypertension, congenital or acquired heart dieses
exclusion critreria: duration of surgery more than 2 hours, another operation at the same time, complication in or after operation

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ausea. Timepoint: 1hrs,2hrs,6hrs,12hrs after surgery. Method of measurement: VAS.
Secondary Outcome Measures
NameTimeMethod
Vomiting. Timepoint: 1hrs,2hrs,6hrs,12hrs after surgery. Method of measurement: VAS.
© Copyright 2025. All Rights Reserved by MedPath